Search Orphan Drug Designations and Approvals
-
Generic Name: | iloprost |
---|---|
Date Designated: | 05/09/2019 |
Orphan Designation: | Treatment of systemic sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Eicos Sciences, Inc., a CiVi Biopharma, Inc. affiliated company 200 Four Falls Corporate Center Suite 107 West Conshohocken, Pennsylvania 19528 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-